Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGPhase 1 / Phase 2INTERVENTIONAL

A Chatbot to Support Substance Use Recovery

A Conversational Agent to Support Follow-up Care for Individuals in Recovery for Substance Use Disorder

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this clinical trial is to learn if/how an AI chatbot can support patients who in recovery for substance use, specifically those who are receiving medication for opioid use disorder. Can the chatbot help lower drug use? Can the chatbot help improve clinical appointment adherence? Can the chatbot help patients build self-efficacy in leading their own recovery journey? Will the chatbot help reduce workload burden for primary care teams? Can the chatbot serve as a safe, useful and engaging tool to support patients? Researchers will investigate the effects of using a chatbot to support follow-up care for patients in opioid use recovery. Participants will: * Receive access to a chatbot for 12 weeks that they can use to prepare for upcoming clinical appointments, find community resources, learn about urge-surfing and wellness techniques, and query for assistance with other recovery-related information and tasks * Complete surveys and provide user feedback

Who May Be Eligible (Plain English)

Who May Qualify: - 18-65 years old - Comfortable with reading, understanding, and communicating in English - Receiving medication treatment for OUD at MGH? - Able to participate in a remote interview? - Own or have reliable access to Wi-Fi or a cellular network - Willing to use a mobile device to access the chatbot? Who Should NOT Join This Trial: - Has any cognitive, visual, or auditory impairments that may prevent the participant from using the chatbot on a mobile device? - Unstable medical condition that compromises the ability to safely participate Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * 18-65 years old * Comfortable with reading, understanding, and communicating in English * Receiving medication treatment for OUD at MGH? * Able to participate in a remote interview? * Own or have reliable access to Wi-Fi or a cellular network * Willing to use a mobile device to access the chatbot? Exclusion Criteria: * Has any cognitive, visual, or auditory impairments that may prevent the participant from using the chatbot on a mobile device? * Unstable medical condition that compromises the ability to safely participate

Treatments Being Tested

OTHER

chatbot

Participants will: * Participate in a baseline session to complete an initial survey and get trained on using the chatbot * Use the chatbot for 12 weeks and submit a brief weekly survey to provide feedback * Complete a final survey to provide substance use and health information as well as give feedback on the experience using the chatbot * Allow access to a limited set of demographic, substance use and health information in electronic health record for study analyses and context.

Locations (1)

Massachusetts General Hospital
Boston, Massachusetts, United States